Dianthus Therapeutics Stock Price Prediction
| DNTH Stock | 22.34 2.07 10.21% |
Oversold Vs Overbought
47
Oversold | Overbought |
EPS Estimate Next Quarter (0.65) | Wall Street Target Price 51.8 | EPS Estimate Current Quarter (0.59) | Quarterly Revenue Growth 1.351 |
Using Dianthus Therapeutics hype-based prediction, you can estimate the value of Dianthus Therapeutics from the perspective of Dianthus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Dianthus Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Dianthus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Dianthus Therapeutics after-hype prediction price | USD 23.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Dianthus |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dianthus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dianthus Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Dianthus Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dianthus Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Dianthus Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Dianthus Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Dianthus Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dianthus Therapeutics' historical news coverage. Dianthus Therapeutics' after-hype downside and upside margins for the prediction period are 19.31 and 26.95, respectively. We have considered Dianthus Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Dianthus Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Dianthus Therapeutics is based on 3 months time horizon.
Dianthus Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Dianthus Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dianthus Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dianthus Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 3.82 | 0.66 | 0.01 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
22.34 | 23.13 | 3.54 |
|
Dianthus Therapeutics Hype Timeline
Dianthus Therapeutics is currently traded for 22.34. The entity has historical hype elasticity of 0.66, and average elasticity to hype of competition of -0.01. Dianthus is anticipated to increase in value after the next headline, with the price projected to jump to 23.13 or above. The average volatility of media hype impact on the company the price is about 179.34%. The price growth on the next news is projected to be 3.54%, whereas the daily expected return is currently at -0.31%. The volatility of related hype on Dianthus Therapeutics is about 9550.0%, with the expected price after the next announcement by competition of 22.33. Dianthus Therapeutics currently holds 585 K in liabilities. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Dianthus Therapeutics Basic Forecasting Models to cross-verify your projections.Dianthus Therapeutics Related Hype Analysis
Having access to credible news sources related to Dianthus Therapeutics' direct competition is more important than ever and may enhance your ability to predict Dianthus Therapeutics' future price movements. Getting to know how Dianthus Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dianthus Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.20) | 6.21 | (9.35) | 34.87 | |
| HCWB | HCW Biologics | 0.01 | 5 per month | 7.39 | 0.1 | 22.00 | (13.64) | 352.85 | |
| SCPH | Scpharmaceuticals | (0.30) | 7 per month | 0.00 | (0.20) | 4.30 | (7.09) | 20.70 | |
| MIST | Milestone Pharmaceuticals | (0.01) | 6 per month | 1.60 | 0.1 | 7.19 | (2.11) | 18.66 | |
| MCRB | Seres Therapeutics | (0.06) | 9 per month | 5.68 | (0.02) | 10.00 | (9.78) | 28.84 | |
| LUMO | Lumos Pharma | (0.13) | 6 per month | 2.60 | 0.11 | 6.35 | (5.19) | 26.13 |
Dianthus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Dianthus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dianthus using various technical indicators. When you analyze Dianthus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Dianthus Therapeutics Predictive Indicators
The successful prediction of Dianthus Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Dianthus Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Dianthus Therapeutics based on analysis of Dianthus Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Dianthus Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Dianthus Therapeutics's related companies. | 2022 | 2023 (projected) | Payables Turnover | 0.13 | 0.14 | Days Of Inventory On Hand | 2.1K | 1.9K |
Story Coverage note for Dianthus Therapeutics
The number of cover stories for Dianthus Therapeutics depends on current market conditions and Dianthus Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dianthus Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dianthus Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Dianthus Therapeutics Short Properties
Dianthus Therapeutics' future price predictability will typically decrease when Dianthus Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dianthus Therapeutics often depends not only on the future outlook of the potential Dianthus Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dianthus Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.2 M | |
| Cash And Short Term Investments | 173.7 M |
Complementary Tools for Dianthus Stock analysis
When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |